Andere Sprachen Nightingale Health Oyj

Aktien

A2QR4M

FI4000490875

HEALTH

Markt geschlossen - Nasdaq Helsinki Andere Börsenplätze 17:17:47 31.05.2024			% 5 Tage	% 1. Jan.
1.73 ^EUR	+1.76%		+2.06%	+55.02%

16.04.	Nightingale Health wird ein Labor in den Vereinigten Staaten einrichten	CI
16.04.	Nightingale Health und das Englander Institute for Precision Medicine at Weill Cornell Medicine unterzeichnen eine Absichtserklärung, in der sich die Parteien auf eine Zusammenarbeit bei der Einführung der proprietären Technologie von Nightingale Health im Gesundheitswesen und in der medizinischen Forschung in den Vereinigten Staaten verständigen	CI

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Nightingale Health to Establish A Laboratory in the United States	16.04.
Nightingale Health and the Englander Institute for Precision Medicine At Weill Cornell Medicine Sign A Letter of Intent in Which the Parties Agree to Collaborate on the Adoption of Nightingale Health's Proprietary Technology in Healthcare and Medical Research in the United States	16.04.
Nightingale Health Secures Blood Analysis Contract with Kaiser Foundation	12.04.
Nightingale Health Enters into Agreement to Analyze 50,000 Blood Samples with Kaiser Foundation Health Plan, Inc	12.04.
Nightingale Health Closes Purchase of Japan's Welltus	29.03.
Nightingale Health Oyj completed the acquisition of Welltus Inc from Mitsui & Co., Ltd. and Kirin Holdings Company, Limited.	29.03.
Nightingale Health plc Enters into an Agreement in Which It Will Analyze Blood Samples from Uganda's General Population Cohort	19.03.
Finland-based Nightingale Health to Buy Japan's Welltus	07.03.
Transcript : Nightingale Health Oyj, H1 2024 Earnings Call, Mar 07, 2024	07.03.
Nightingale Health Oyj Reports Earnings Results for the Half Year Ended December 30, 2023	07.03.
Nightingale Health plc Receives Five New Patents for Its Proprietary Health Risk Detection Capability	31.01.
Suomen Terveystalo Begins Using Nightingale Health's Blood Analysis Technology in Regular Health Checks in Occupational Health	02.01.
Terveystalo Integrates Nightingale Health's Blood Analysis Technology in Occupational Health	02.01.
Nightingale Health Completes the Analysis of All 500,000 UK Biobank Samples Creating the Largest Blood Biomarker Database for Chronic Disease Research and Prevention	13.12.
Nightingale Health plc Announces Maximilian Leroux Leaves as Chief Commercial Officer	27.11.
Nightingale Health and Innoquest Diagnostics Enter into Collaboration Agreement to Make Nightingale Health's Technology Accessible in the Southeast Asia Region	15.11.
Transcript : Nightingale Health Oyj, 2023 Earnings Call, Sep 28, 2023	28.09.23
Nightingale Health Oyj Reports Earnings Results for the Full Year Ended June 30, 2023	28.09.23
Nightingale Health Receives Three New Patents Further Strengthening Its IP Portfolio	26.09.23
Nightingale Health plc to Set Up Its UK Laboratory in Porton Science Park in South Wiltshire	19.09.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Nightingale Health Oyj

Aktien

A2QR4M

FI4000490875

HEALTH

Andere Sprachen

Filter